| Year |
Citation |
Score |
| 2023 |
Reiss AB, Muhieddine D, Jacob B, Mesbah M, Pinkhasov A, Gomolin IH, Stecker MM, Wisniewski T, De Leon J. Alzheimer's Disease Treatment: The Search for a Breakthrough. Medicina (Kaunas, Lithuania). 59. PMID 37374288 DOI: 10.3390/medicina59061084 |
0.315 |
|
| 2022 |
Parasoglou P, Osorio RS, Khegai O, Kovbasyuk Z, Miller M, Ho A, Dehkharghani S, Wisniewski T, Convit A, Mosconi L, Brown R. Phosphorus metabolism in the brain of cognitively normal midlife individuals at risk for Alzheimer's disease. Neuroimage. Reports. 2. PMID 36532654 DOI: 10.1016/j.ynirp.2022.100121 |
0.307 |
|
| 2022 |
Drummond E, Kavanagh T, Pires G, Marta-Ariza M, Kanshin E, Nayak S, Faustin A, Berdah V, Ueberheide B, Wisniewski T. The amyloid plaque proteome in early onset Alzheimer's disease and Down syndrome. Acta Neuropathologica Communications. 10: 53. PMID 35418158 DOI: 10.1186/s40478-022-01356-1 |
0.354 |
|
| 2021 |
Liu H, Kim C, Haldiman T, Sigurdson CJ, Nyström S, Nilsson KPR, Cohen ML, Wisniewski T, Hammarström P, Safar JG. Distinct conformers of amyloid beta accumulate in the neocortex of patients with rapidly progressive Alzheimer's disease. The Journal of Biological Chemistry. 101267. PMID 34599965 DOI: 10.1016/j.jbc.2021.101267 |
0.341 |
|
| 2021 |
Wang M, Lv J, Huang X, Wisniewski T, Zhang W. High-fat diet-induced atherosclerosis promotes neurodegeneration in the triple transgenic (3 × Tg) mouse model of Alzheimer's disease associated with chronic platelet activation. Alzheimer's Research & Therapy. 13: 144. PMID 34454596 DOI: 10.1186/s13195-021-00890-9 |
0.329 |
|
| 2021 |
Patel AG, Nehete PN, Krivoshik SR, Pei X, Cho EL, Nehete BP, Ramani MD, Shao Y, Williams LE, Wisniewski T, Scholtzova H. Innate immunity stimulation via CpG oligodeoxynucleotides ameliorates Alzheimer's disease pathology in aged squirrel monkeys. Brain : a Journal of Neurology. PMID 34128045 DOI: 10.1093/brain/awab129 |
0.328 |
|
| 2021 |
Boutajangout A, Zhang W, Kim J, Abdali WA, Prelli F, Wisniewski T. Passive Immunization With a Novel Monoclonal Anti-PrP Antibody TW1 in an Alzheimer's Mouse Model With Tau Pathology. Frontiers in Aging Neuroscience. 13: 640677. PMID 33716717 DOI: 10.3389/fnagi.2021.640677 |
0.3 |
|
| 2020 |
Dyakin VV, Wisniewski TM, Lajtha A. Chiral Interface of Amyloid Beta (Aβ): Relevance to Protein Aging, Aggregation and Neurodegeneration. Symmetry. 12. PMID 34327009 DOI: 10.3390/sym12040585 |
0.328 |
|
| 2020 |
Drummond E, Pires G, MacMurray C, Askenazi M, Nayak S, Bourdon M, Safar J, Ueberheide B, Wisniewski T. Phosphorylated tau interactome in the human Alzheimer's disease brain. Brain : a Journal of Neurology. PMID 32812023 DOI: 10.1093/Brain/Awaa223 |
0.378 |
|
| 2020 |
Reiss AB, Glass AD, Wisniewski T, Wolozin B, Gomolin IH, Pinkhasov A, De Leon J, Stecker MM. Alzheimer's disease: many failed trials, so where do we go from here? Journal of Investigative Medicine : the Official Publication of the American Federation For Clinical Research. 68: 1135-1140. PMID 32699179 DOI: 10.1136/Jim-2020-001297 |
0.439 |
|
| 2020 |
Hickman RA, Flowers XE, Wisniewski T. Primary Age-Related Tauopathy (PART): Addressing the Spectrum of Neuronal Tauopathic Changes in the Aging Brain. Current Neurology and Neuroscience Reports. 20: 39. PMID 32666342 DOI: 10.1007/S11910-020-01063-1 |
0.31 |
|
| 2020 |
Reisberg B, Shao Y, Moosavi M, Kenowsky S, Vedvyas A, Marsh K, Bao J, Buj M, Torossian C, Kluger A, Vedvyas G, Oo T, Malik F, Arain F, Masurkar AV, ... Wisniewski T, et al. Psychometric Cognitive Decline Precedes the Advent of Subjective Cognitive Decline in the Evolution of Alzheimer's Disease. Dementia and Geriatric Cognitive Disorders. 1-6. PMID 32388509 DOI: 10.1159/000507286 |
0.35 |
|
| 2020 |
Nehete PN, Williams LE, Chitta S, Nehete BP, Patel AG, Ramani MD, Wisniewski T, Scholtzova H. Class C CpG Oligodeoxynucleotide Immunomodulatory Response in Aged Squirrel Monkey (). Frontiers in Aging Neuroscience. 12: 36. PMID 32194391 DOI: 10.3389/Fnagi.2020.00036 |
0.371 |
|
| 2020 |
Devanand DP, Andrews H, Kreisl WC, Razlighi Q, Gershon A, Stern Y, Mintz A, Wisniewski T, Acosta E, Pollina J, Katsikoumbas M, Bell KL, Pelton GH, Deliyannides D, Prasad KM, et al. Antiviral therapy: Valacyclovir Treatment of Alzheimer's Disease (VALAD) Trial: protocol for a randomised, double-blind,placebo-controlled, treatment trial. Bmj Open. 10: e032112. PMID 32034019 DOI: 10.1136/Bmjopen-2019-032112 |
0.401 |
|
| 2020 |
Wisniewski T, Drummond E. APOE-amyloid interaction: Therapeutic targets. Neurobiology of Disease. 104784. PMID 32027932 DOI: 10.1016/J.Nbd.2020.104784 |
0.439 |
|
| 2019 |
Pires G, McElligott S, Drusinsky S, Halliday G, Potier MC, Wisniewski T, Drummond E. Secernin-1 is a novel phosphorylated tau binding protein that accumulates in Alzheimer's disease and not in other tauopathies. Acta Neuropathologica Communications. 7: 195. PMID 31796108 DOI: 10.1186/S40478-019-0848-6 |
0.444 |
|
| 2019 |
Wisniewski T, Drummond E. Future horizons in Alzheimer's disease research. Progress in Molecular Biology and Translational Science. 168: 223-241. PMID 31699317 DOI: 10.1016/Bs.Pmbts.2019.08.001 |
0.422 |
|
| 2019 |
Martino Adami PV, Nichtová Z, Weaver DB, Bartok A, Wisniewski T, Jones DR, Do Carmo S, Castaño EM, Cuello AC, Hajnóczky G, Morelli L. Perturbed mitochondria-ER contacts in live neurons modelling Alzheimer's disease amyloid pathology. Journal of Cell Science. PMID 31515277 DOI: 10.1242/Jcs.229906 |
0.394 |
|
| 2019 |
Wisniewski T. Follow-up of active Aβ immunization in Alzheimer disease. Nature Reviews. Neurology. PMID 31308505 DOI: 10.1038/S41582-019-0239-4 |
0.443 |
|
| 2019 |
Boutajangout A, Lindberg H, Awwad A, Paul A, Baitalmal R, Almokyad I, Höidén-Guthenberg I, Gunneriusson E, Frejd FY, Härd T, Löfblom J, Ståhl S, Wisniewski T. Affibody-Mediated Sequestration of Amyloid β Demonstrates Preventive Efficacy in a Transgenic Alzheimer's Disease Mouse Model. Frontiers in Aging Neuroscience. 11: 64. PMID 30967771 DOI: 10.3389/Fnagi.2019.00064 |
0.484 |
|
| 2019 |
Rubenstein R, Sharma DR, Chang B, Oumata N, Cam M, Vaucelle L, Lindberg MF, Chiu A, Wisniewski T, Wang KKW, Meijer L. Novel Mouse Tauopathy Model for Repetitive Mild Traumatic Brain Injury: Evaluation of Long-Term Effects on Cognition and Biomarker Levels After Therapeutic Inhibition of Tau Phosphorylation. Frontiers in Neurology. 10: 124. PMID 30915013 DOI: 10.3389/Fneur.2019.00124 |
0.38 |
|
| 2019 |
Lu H, Wang XD, Shi Z, Yue W, Zhang Y, Liu S, Liu S, Zhao L, Xiang L, Zhang Y, Guan Y, Su W, Li Z, Wang J, Wisniewski T, et al. Comparative analysis of cognitive impairment prevalence and its etiological subtypes in a rural area of northern China between 2010 and 2015. Scientific Reports. 9: 851. PMID 30696930 DOI: 10.1038/S41598-018-37286-Z |
0.302 |
|
| 2019 |
Drummond E, Pires G, MacMurray C, Askenazi M, Nayak S, Bourdon M, Ueberheide B, Wisniewski T. P4-530: Phosphorylated Tau Interactome In The Human Alzheimer'S Disease Brain Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.08.077 |
0.39 |
|
| 2019 |
Drummond E, Berdah V, Nayak S, Pires G, Ueberheide B, Wisniewski T. P1-155: Differences In The Amyloid Plaque Proteome In Down Syndrome Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.710 |
0.347 |
|
| 2019 |
Pires G, Prelli F, Halliday GM, McElligott S, Drusinsky S, Wisniewski T, Drummond E. O4-01-06: Secernin-1 Is A Novel Phosphorylated Tau Binding Protein That Accumulates In Alzheimer'S Disease And Not In Other Tauopathies Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4745 |
0.369 |
|
| 2019 |
Goni F, Pires G, Marta-Ariza M, Wisniewski T. P1-082: THERAPEUTICALLY EFFICACIOUS ANTI-β-SHEET MONOCLONAL DOES NOT INDUCE MICROHEMORRHAGES OR INFLAMMATION IN TGSWDI AD MICE WITH EXTENSIVE VASCULAR AMYLOID, INCREASING CHANCES OF SAFE TRANSLATABILITY Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.107 |
0.399 |
|
| 2018 |
Zhu R, Pan YH, Sun L, Zhang T, Wang C, Ye S, Yang N, Lu T, Wisniewski T, Dang S, Zhang W. ADAMTS18 deficiency affects neuronal morphogenesis and reduces the levels of depression-like behaviors in mice. Neuroscience. PMID 30579834 DOI: 10.1016/J.Neuroscience.2018.12.025 |
0.304 |
|
| 2018 |
Herline K, Drummond E, Wisniewski T. Recent advancements toward therapeutic vaccines against alzheimer's disease. Expert Review of Vaccines. PMID 30005578 DOI: 10.1080/14760584.2018.1500905 |
0.471 |
|
| 2018 |
Herline K, Prelli F, Mehta P, MacMurray C, Goñi F, Wisniewski T. Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model. Alzheimer's Research & Therapy. 10: 54. PMID 29914551 DOI: 10.1186/S13195-018-0384-9 |
0.484 |
|
| 2018 |
Solesio ME, Peixoto PM, Debure L, Madamba SM, de Leon MJ, Wisniewski T, Pavlov EV, Fossati S. Carbonic anhydrase inhibition selectively prevents amyloid β neurovascular mitochondrial toxicity. Aging Cell. e12787. PMID 29873184 DOI: 10.1111/Acel.12787 |
0.377 |
|
| 2018 |
Drummond E, Goñi F, Liu S, Prelli F, Scholtzova H, Wisniewski T. Potential Novel Approaches to Understand the Pathogenesis and Treat Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 29562516 DOI: 10.3233/Jad-179909 |
0.426 |
|
| 2018 |
Mehta PD, Patrick BA, Barshatzky M, Mehta SP, Frackowiak J, Mazur-Kolecka B, Wegiel J, Wisniewski T, Miller DL. Generation and Partial Characterization of Rabbit Monoclonal Antibody to Pyroglutamate Amyloid-β3-42 (pE3-Aβ). Journal of Alzheimer's Disease : Jad. PMID 29504532 DOI: 10.3233/Jad-170898 |
0.439 |
|
| 2018 |
Ramos-Cejudo J, Wisniewski T, Marmar C, Zetterberg H, Blennow K, de Leon MJ, Fossati S. Traumatic Brain Injury and Alzheimer's Disease: The Cerebrovascular Link. Ebiomedicine. PMID 29396300 DOI: 10.1016/J.Ebiom.2018.01.021 |
0.425 |
|
| 2018 |
Goñi F, Martá-Ariza M, Herline K, Peyser D, Boutajangout A, Mehta P, Drummond E, Prelli F, Wisniewski T. Anti-β-sheet conformation monoclonal antibody reduces tau and Aβ oligomer pathology in an Alzheimer's disease model. Alzheimer's Research & Therapy. 10: 10. PMID 29378642 DOI: 10.1186/S13195-018-0337-3 |
0.458 |
|
| 2018 |
Drummond E, Nayak S, Pires G, Ueberheide B, Wisniewski T. Isolation of Amyloid Plaques and Neurofibrillary Tangles from Archived Alzheimer's Disease Tissue Using Laser-Capture Microdissection for Downstream Proteomics. Methods in Molecular Biology (Clifton, N.J.). 1723: 319-334. PMID 29344869 DOI: 10.1007/978-1-4939-7558-7_18 |
0.408 |
|
| 2018 |
Wenning G, Trojanowski JQ, Kaufmann H, Rocca WA, Wisniewski T, Low PA. Is Multiple System Atrophy An Infectious Disease? Annals of Neurology. PMID 29293269 DOI: 10.1002/Ana.25132 |
0.31 |
|
| 2018 |
Boutajangout A, Abdali W, Kim JST, Wisniewski T. P4-223: Passive Immunization With The Novel Monoclonal Anti-Prp Antibody Tw1 In An Alzheimer'S Mouse Model Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.07.044 |
0.335 |
|
| 2018 |
Drummond E, Pires G, Prelli F, McElligott S, Drusinsky S, Wisniewski T. P2-170: Secernin-1 Is A Novel Early Marker Of Neurofibrillary Tangles In Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.857 |
0.393 |
|
| 2018 |
Drummond E, Goni F, Prelli F, Scholtzova H, Wisniewski T. F4-06-03: Insights From Neuropathology And Modulation Of Innate Immunity As A Therapeutic Approach For Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2886 |
0.332 |
|
| 2018 |
Prelli F, Drummond E, Pires G, Nayak S, Ueberheide B, Wisniewski T. P1-243: Secernin-1: A Novel Amyloid Plaque And Oligomer Species Associated Protein Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.248 |
0.355 |
|
| 2018 |
Angiulli F, Solesio ME, Debure L, Cejudo JR, Wisniewski T, Fossati S. P3-464: Carbonic Anhydrase Inhibitors Ameliorate Neurovascular Dysfunction In A Mouse Model Of Cerebral Amyloid Angiopathy Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1828 |
0.317 |
|
| 2017 |
Goñi F, Martá-Ariza M, Peyser D, Herline K, Wisniewski T. Production of Monoclonal Antibodies to Pathologic β-sheet Oligomeric Conformers in Neurodegenerative Diseases. Scientific Reports. 7: 9881. PMID 28852189 DOI: 10.1038/S41598-017-10393-Z |
0.369 |
|
| 2017 |
Liu S, Park S, Allington G, Prelli F, Sun Y, Martá-Ariza M, Scholtzova H, Biswas G, Brown B, Verghese PB, Mehta PD, Kwon YU, Wisniewski T. Targeting Apolipoprotein E/Amyloid β Binding by Peptoid CPO_Aβ17-21 P Ameliorates Alzheimer's Disease Related Pathology and Cognitive Decline. Scientific Reports. 7: 8009. PMID 28808293 DOI: 10.1038/S41598-017-08604-8 |
0.472 |
|
| 2017 |
Drummond E, Wisniewski T. The use of localized proteomics to identify the drivers of Alzheimer's disease pathogenesis. Neural Regeneration Research. 12: 912-913. PMID 28761421 DOI: 10.4103/1673-5374.208570 |
0.375 |
|
| 2017 |
Rubenstein R, Chang B, Grinkina N, Drummond E, Davies P, Ruditzky M, Sharma D, Wang K, Wisniewski T. Tau phosphorylation induced by severe closed head traumatic brain injury is linked to the cellular prion protein. Acta Neuropathologica Communications. 5: 30. PMID 28420443 DOI: 10.1186/S40478-017-0435-7 |
0.403 |
|
| 2017 |
Drummond E, Nayak S, Faustin A, Pires G, A Hickman R, Askenazi M, Cohen M, Haldiman T, Kim C, Han X, Shao Y, Safar JG, Ueberheide B, Wisniewski T. Proteomic differences in amyloid plaques in rapidly progressive and sporadic Alzheimer's disease. Acta Neuropathologica. PMID 28258398 DOI: 10.1007/S00401-017-1691-0 |
0.424 |
|
| 2017 |
Scholtzova H, Do E, Dhakal S, Sun Y, Liu S, Mehta PD, Wisniewski T. Innate Immunity Stimulation via Toll-Like Receptor 9 Ameliorates Vascular Amyloid Pathology in Tg-SwDI Mice with Associated Cognitive Benefits. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 37: 936-959. PMID 28123027 DOI: 10.1523/Jneurosci.1967-16.2016 |
0.465 |
|
| 2017 |
Liu S, Allington G, Prelli F, Sun Y, Marta-Ariza M, Mehta PD, Scholtzova H, Brown B, Kwon Y, Wisniewski T. TARGETING THE APOLIPOPROTEIN E/AMYLOID β INTERACTION BY CPO_A β 17-21P, A NON-TOXIC AND NON-FIBRILLOGENIC PEPTOID, AMELIORATED A β -RELATED PATHOLOGY AND IMPROVED COGNITIVE DECLINE IN A MOUSE MODEL OF ALZHEIMER’S DISEASE Alzheimers & Dementia. 13: 1506. DOI: 10.1016/J.Jalz.2017.07.619 |
0.33 |
|
| 2017 |
Goni F, Herline K, Marta-Ariza M, Boutajangout A, Mehta PD, Prelli F, Wisniewski T. A MONOCLONAL ANTI-OLIGOMER IGM CROSSES THE BBB AND PRODUCES COGNITIVE RESCUE BY LOWERING OLIGOMERIC FORMS OF BOTH TAU AND Aβ IN AN AD ANIMAL MODEL Alzheimers & Dementia. 13: 1487. DOI: 10.1016/J.Jalz.2017.07.568 |
0.393 |
|
| 2017 |
Scholtzova H, Nehete PN, Nehete BP, Pei X, Krivoshik SR, Patel AG, Padova A, Andrade AG, Alu MJ, Mehta PD, Williams LE, Wisniewski T. Cerebral Amyloid Angiopathy Treatment Via Innate Immunity Stimulation In Aged Non-Human Primates Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.1263 |
0.308 |
|
| 2016 |
Drummond E, Wisniewski T. Alzheimer's disease: experimental models and reality. Acta Neuropathologica. PMID 28025715 DOI: 10.1007/S00401-016-1662-X |
0.432 |
|
| 2016 |
Scholtzova H, Do E, Dhakal S, Sun Y, Liu S, Mehta PD, Wisniewski T. Innate Immunity Stimulation via Toll-like Receptor 9 Ameliorates Vascular Amyloid Pathology in Tg-SwDI mice with Associated Cognitive Benefits. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 27980116 DOI: 10.1523/JNEUROSCI.1967-16.2016 |
0.361 |
|
| 2016 |
Hickman RA, Faustin A, Wisniewski T. Alzheimer Disease and Its Growing Epidemic: Risk Factors, Biomarkers, and the Urgent Need for Therapeutics. Neurologic Clinics. 34: 941-953. PMID 27720002 DOI: 10.1016/J.Ncl.2016.06.009 |
0.381 |
|
| 2016 |
Boutajangout A, Noorwali A, Atta H, Wisniewski T. Human Umbilical Cord Stem Cell Xenografts Improve Cognitive Decline and Reduce the Amyloid Burden in a Mouse Model of Alzheimer's Disease. Current Alzheimer Research. PMID 27719629 DOI: 10.2174/1567205013666161004151416 |
0.394 |
|
| 2016 |
Pomara N, Bruno D, Osorio RS, Reichert C, Nierenberg J, Sarreal AS, Hernando RT, Marmar CR, Wisniewski T, Zetterberg H, Blennow K. State-dependent alterations in cerebrospinal fluid Aβ42 levels in cognitively intact elderly with late-life major depression. Neuroreport. PMID 27508979 DOI: 10.1097/Wnr.0000000000000658 |
0.328 |
|
| 2016 |
Wisniewski T, Pratico D. Down syndrome dementia and Alzheimer disease: common pathology, common therapeutic targets Neurobiology of Aging. 39. DOI: 10.1016/J.Neurobiolaging.2016.01.106 |
0.377 |
|
| 2016 |
Drummond E, Nayak S, Faustin A, Pires G, Hickman R, Safar J, Askenazi M, Cohen M, Haldiman T, Kim C, Ueberheide B, Wisniewski T. Altered Protein Expression In Amyloid Plaques In Rapidly Progressive Alzheimer’S Disease Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.723 |
0.413 |
|
| 2016 |
Goni F, Herline K, Marta-Ariza M, Boutajangout A, Mehta PD, Prelli F, Wisniewski T. Disease Modifying Therapy By The Infusion Of An Anti-Conformational Monoclonal Antibody In An Ab And Tau 3Xtg Mouse Model Of Alzheimer’S Disease Alzheimers & Dementia. 12: 360. DOI: 10.1016/J.Jalz.2016.06.667 |
0.334 |
|
| 2016 |
Boutajangout A, Lindberg H, Awwad A, Paul A, Baitalmal R, Gudmundsdotter L, Wahlberg E, Hard T, Lofblom J, Stahl S, Wisniewski T. AN AFFIBODY TO MONOMERIC Aβ AS A NOVEL THERAPEUTIC APPROACH FOR ALZHEIMER'S DISEASE PATHOLOGY Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.1708 |
0.441 |
|
| 2015 |
Kovacs GG, Ferrer I, Grinberg LT, Alafuzoff I, Attems J, Budka H, Cairns NJ, Crary JF, Duyckaerts C, Ghetti B, Halliday GM, Ironside JW, Love S, Mackenzie IR, Munoz DG, ... ... Wisniewski T, et al. Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy. Acta Neuropathologica. PMID 26659578 DOI: 10.1007/S00401-015-1509-X |
0.346 |
|
| 2015 |
Wisniewski T, Drummond E. Developing Therapeutic Vaccines Against Alzheimer's Disease. Expert Review of Vaccines. PMID 26577574 DOI: 10.1586/14760584.2016.1121815 |
0.458 |
|
| 2015 |
Drummond ES, Nayak S, Ueberheide B, Wisniewski T. Proteomic analysis of neurons microdissected from formalin-fixed, paraffin-embedded Alzheimer's disease brain tissue. Scientific Reports. 5: 15456. PMID 26487484 DOI: 10.1038/Srep15456 |
0.317 |
|
| 2015 |
Chu J, Wisniewski T, Praticò D. GATA1-mediated transcriptional regulation of the γ-secretase activating protein increases Aβ formation in Down syndrome. Annals of Neurology. PMID 26448035 DOI: 10.1002/Ana.24540 |
0.37 |
|
| 2015 |
Spiegel J, Pirraglia E, Li Y, Tsui W, Glodzik L, Osorio RS, Saint Louis LA, Randall C, Butler T, Xu J, Zinkowski RP, Zetterberg H, Fortea J, Fossati S, Wisniewski T, et al. Greater Specificity for Cerebrospinal Fluid P-tau231 over P-tau181 in the Differentiation of Healthy Controls from Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 26444757 DOI: 10.3233/Jad-150167 |
0.369 |
|
| 2015 |
Teoh CL, Su D, Sahu S, Yun SW, Drummond E, Prelli F, Lim S, Cho S, Ham S, Wisniewski T, Chang YT. Chemical Fluorescent Probe for Detection of Aβ Oligomers. Journal of the American Chemical Society. PMID 26218347 DOI: 10.1021/Jacs.5B06190 |
0.411 |
|
| 2015 |
Tarasoff-Conway JM, Carare RO, Osorio RS, Glodzik L, Butler T, Fieremans E, Axel L, Rusinek H, Nicholson C, Zlokovic BV, Frangione B, Blennow K, Ménard J, Zetterberg H, Wisniewski T, et al. Clearance systems in the brain-implications for Alzheimer disease. Nature Reviews. Neurology. PMID 26195256 DOI: 10.1038/Nrneurol.2015.119 |
0.46 |
|
| 2015 |
Ji Y, Shi Z, Zhang Y, Liu S, Liu S, Yue W, Liu M, Huo YR, Wang J, Wisniewski T. Prevalence of dementia and main subtypes in rural northern China. Dementia and Geriatric Cognitive Disorders. 39: 294-302. PMID 25792116 DOI: 10.1159/000375366 |
0.332 |
|
| 2015 |
Wisniewski T, Goñi F. Immunotherapeutic approaches for Alzheimer's disease. Neuron. 85: 1162-76. PMID 25789753 DOI: 10.1016/J.Neuron.2014.12.064 |
0.466 |
|
| 2015 |
Jellinger KA, Alafuzoff I, Attems J, Beach TG, Cairns NJ, Crary JF, Dickson DW, Hof PR, Hyman BT, Jack CR, Jicha GA, Knopman DS, Kovacs GG, Mackenzie IR, Masliah E, ... ... Wisniewski T, et al. PART, a distinct tauopathy, different from classical sporadic Alzheimer disease. Acta Neuropathologica. 129: 757-62. PMID 25778618 DOI: 10.1007/S00401-015-1407-2 |
0.447 |
|
| 2015 |
Goñi F, Mathiason CK, Yim L, Wong K, Hayes-Klug J, Nalls A, Peyser D, Estevez V, Denkers N, Xu J, Osborn DA, Miller KV, Warren RJ, Brown DR, Chabalgoity JA, ... ... Wisniewski T, et al. Mucosal immunization with an attenuated Salmonella vaccine partially protects white-tailed deer from chronic wasting disease. Vaccine. 33: 726-33. PMID 25539804 DOI: 10.1016/J.Vaccine.2014.11.035 |
0.315 |
|
| 2015 |
Hartley D, Blumenthal T, Carrillo M, DiPaolo G, Esralew L, Gardiner K, Granholm AC, Iqbal K, Krams M, Lemere C, Lott I, Mobley W, Ness S, Nixon R, Potter H, ... ... Wisniewski T, et al. Down syndrome and Alzheimer's disease: Common pathways, common goals. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 700-9. PMID 25510383 DOI: 10.1016/J.Jalz.2014.10.007 |
0.399 |
|
| 2015 |
Goni F, Scholtzova H, Marta-Ariza M, Herline K, Sun Y, Pan J, Mehta PD, Wisniewski T. Active vaccination of old Alzheimer’s disease transgenic animals with oligomeric polymerized pbri and cpg odn can reverse preexisting Alzheimer's disease pathology Alzheimers & Dementia. 11: 617. DOI: 10.1016/J.Jalz.2015.06.863 |
0.39 |
|
| 2015 |
Goni F, Herline K, Drummond E, Marta-Ariza M, Prelli F, Wisniewski T. Monoclonal antibodies that recognize oligomeric tau and Aβ also recognize pathological structures in parkinson’s disease human brains Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.06.1881 |
0.396 |
|
| 2014 |
Yaghmoor F, Noorsaeed A, Alsaggaf S, Aljohani W, Scholtzova H, Boutajangout A, Wisniewski T. The Role of TREM2 in Alzheimer's Disease and Other Neurological Disorders. Journal of Alzheimer's Disease & Parkinsonism. 4. PMID 25664220 DOI: 10.4172/2161-0460.1000160 |
0.377 |
|
| 2014 |
Sabharwal P, Wisniewski T. Novel immunological approaches for the treatment of Alzheimer's disease. Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi. 14: 139-151. PMID 25429302 DOI: 10.3969/J.Issn.1672-6731.2014.03.001 |
0.469 |
|
| 2014 |
Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I, Arnold SE, Attems J, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Gearing M, Grinberg LT, Hof PR, ... ... Wisniewski T, et al. Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathologica. 128: 755-66. PMID 25348064 DOI: 10.1007/S00401-014-1349-0 |
0.422 |
|
| 2014 |
Scholtzova H, Chianchiano P, Pan J, Sun Y, Goñi F, Mehta PD, Wisniewski T. Amyloid β and Tau Alzheimer's disease related pathology is reduced by Toll-like receptor 9 stimulation. Acta Neuropathologica Communications. 2: 101. PMID 25178404 DOI: 10.1186/S40478-014-0101-2 |
0.473 |
|
| 2014 |
Boutajangout A, Wisniewski T. Tau-based therapeutic approaches for Alzheimer's disease - a mini-review. Gerontology. 60: 381-5. PMID 24732638 DOI: 10.1159/000358875 |
0.474 |
|
| 2014 |
Iulita MF, Do Carmo S, Ower AK, Fortress AM, Aguilar LF, Hanna M, Wisniewski T, Granholm AC, Buhusi M, Busciglio J, Cuello AC. Nerve growth factor metabolic dysfunction in Down's syndrome brains. Brain : a Journal of Neurology. 137: 860-72. PMID 24519975 DOI: 10.1093/Brain/Awt372 |
0.315 |
|
| 2014 |
Wisniewski T, Goñi F. Immunotherapy for Alzheimer's disease. Biochemical Pharmacology. 88: 499-507. PMID 24412277 DOI: 10.1016/J.Bcp.2013.12.020 |
0.474 |
|
| 2014 |
Liu S, Breitbart A, Sun Y, Mehta PD, Boutajangout A, Scholtzova H, Wisniewski T. Blocking the apolipoprotein E/amyloid β interaction in triple transgenic mice ameliorates Alzheimer's disease related amyloid β and tau pathology. Journal of Neurochemistry. 128: 577-91. PMID 24117759 DOI: 10.1111/Jnc.12484 |
0.485 |
|
| 2014 |
Boutajangout A, Al-Ahwal M, Habıb H, Wısnıewskı T. Immunotherapy Targeting Tau and Amyloid Aβ Pathology in AD Animal Models Neurobiology of Aging. 35: 721. DOI: 10.1016/J.Neurobiolaging.2013.10.058 |
0.416 |
|
| 2014 |
Drummond E, Ueberheide B, Wisniewski T. P1-123: PROTEOMIC ANALYSIS OF ARCHIVED ALZHEIMER'S DISEASE BRAIN TISSUE USING LASER CAPTURE MICRODISSECTION AND LC-MS Alzheimer's & Dementia. 10: P345-P346. DOI: 10.1016/J.Jalz.2014.05.360 |
0.317 |
|
| 2014 |
Wisniewski T, Drummond E, Herline K, Sun Y, Goni F. TARGETING THE SHARED PATHOLOGICAL CONFORMERS OF BOTH Aβ AND HYPERPHOSPHYLATED TAU WITH A CONFORMATIONALLY SELECTIVE MONOCLONAL ANTIBODY Alzheimers & Dementia. 10: 237. DOI: 10.1016/J.Jalz.2014.04.348 |
0.415 |
|
| 2013 |
Goñi F, Herline K, Peyser D, Wong K, Ji Y, Sun Y, Mehta P, Wisniewski T. Immunomodulation targeting of both Aβ and tau pathological conformers ameliorates Alzheimer's disease pathology in TgSwDI and 3xTg mouse models. Journal of Neuroinflammation. 10: 150. PMID 24330773 DOI: 10.1186/1742-2094-10-150 |
0.476 |
|
| 2013 |
Boutajangout A, Wisniewski T. The innate immune system in Alzheimer's disease. International Journal of Cell Biology. 2013: 576383. PMID 24223593 DOI: 10.1155/2013/576383 |
0.445 |
|
| 2013 |
Um JW, Kaufman AC, Kostylev M, Heiss JK, Stagi M, Takahashi H, Kerrisk ME, Vortmeyer A, Wisniewski T, Koleske AJ, Gunther EC, Nygaard HB, Strittmatter SM. Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer aβ oligomer bound to cellular prion protein. Neuron. 79: 887-902. PMID 24012003 DOI: 10.1016/J.Neuron.2013.06.036 |
0.331 |
|
| 2013 |
Wadghiri YZ, Li J, Wang J, Hoang DM, Sun Y, Xu H, Tsui W, Li Y, Boutajangout A, Wang A, de Leon M, Wisniewski T. Detection of amyloid plaques targeted by bifunctional USPIO in Alzheimer's disease transgenic mice using magnetic resonance microimaging. Plos One. 8: e57097. PMID 23468919 DOI: 10.1371/Journal.Pone.0057097 |
0.46 |
|
| 2013 |
Rubenstein R, Chiu A, Chang B, Wisniewski T. Role of CD40 in prion disease and the immune response to recombinant PrP. Journal of Neuroimmunology. 257: 21-7. PMID 23419881 DOI: 10.1016/J.Jneuroim.2013.01.008 |
0.314 |
|
| 2013 |
Wisniewski T, Newman K, Javitt NB. Alzheimer's disease: brain desmosterol levels. Journal of Alzheimer's Disease : Jad. 33: 881-8. PMID 23042211 DOI: 10.3233/Jad-2012-121453 |
0.364 |
|
| 2013 |
Goni F, Herline K, Peyser DK, Wong V, Scholtzoa H, Ji Y, Sun Y, Wisniewski T. Immunomodulation targeting pathology-associated protein conformers in 3xTg and TgSwDI mice Alzheimers & Dementia. 9: 847. DOI: 10.1016/J.Jalz.2013.08.015 |
0.312 |
|
| 2013 |
Scholtzova H, Williams L, Nehete P, Sabado R, Nehete B, Holmes A, Wisniewski T. P2-410: Innate immunity stimulation via TLR9 in a non-human primate model of sporadic cerebral amyloid angiopathy Alzheimer's & Dementia. 9: P508-P508. DOI: 10.1016/J.Jalz.2013.05.1060 |
0.308 |
|
| 2013 |
Goni F, Peyser DK, Herline K, Sun Y, Wisniewski T. Monoclonal antibody therapy targeting the shared pathological conformer of both beta-amyloid and hyperphosphorylated tau Alzheimers & Dementia. 9: 839. DOI: 10.1016/J.Jalz.2013.04.499 |
0.353 |
|
| 2012 |
Potter H, Wisniewski T. Apolipoprotein e: essential catalyst of the Alzheimer amyloid cascade. International Journal of Alzheimer's Disease. 2012: 489428. PMID 22844635 DOI: 10.1155/2012/489428 |
0.42 |
|
| 2012 |
Um JW, Nygaard HB, Heiss JK, Kostylev MA, Stagi M, Vortmeyer A, Wisniewski T, Gunther EC, Strittmatter SM. Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons. Nature Neuroscience. 15: 1227-35. PMID 22820466 DOI: 10.1038/Nn.3178 |
0.398 |
|
| 2012 |
Wisniewski T. Active immunotherapy for Alzheimer's disease. The Lancet. Neurology. 11: 571-2. PMID 22677257 DOI: 10.1016/S1474-4422(12)70136-9 |
0.458 |
|
| 2012 |
Wegiel J, Frackowiak J, Mazur-Kolecka B, Schanen NC, Cook EH, Sigman M, Brown WT, Kuchna I, Wegiel J, Nowicki K, Imaki H, Ma SY, Chauhan A, Chauhan V, Miller DL, ... ... Wisniewski T, et al. Abnormal intracellular accumulation and extracellular Aβ deposition in idiopathic and Dup15q11.2-q13 autism spectrum disorders. Plos One. 7: e35414. PMID 22567102 DOI: 10.1371/Journal.Pone.0035414 |
0.384 |
|
| 2012 |
Wadghiri YZ, Hoang DM, Wisniewski T, Sigurdsson EM. In vivo magnetic resonance imaging of amyloid-β plaques in mice. Methods in Molecular Biology (Clifton, N.J.). 849: 435-51. PMID 22528108 DOI: 10.1007/978-1-61779-551-0_30 |
0.363 |
|
| 2012 |
Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ, Castellani RJ, Crain BJ, Davies P, Del Tredici K, Duyckaerts C, Frosch MP, Haroutunian V, Hof PR, Hulette CM, ... ... Wisniewski T, et al. Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. Journal of Neuropathology and Experimental Neurology. 71: 362-81. PMID 22487856 DOI: 10.1097/Nen.0B013E31825018F7 |
0.404 |
|
| 2012 |
Wisniewski T, Goñi F. Could immunomodulation be used to prevent prion diseases? Expert Review of Anti-Infective Therapy. 10: 307-17. PMID 22397565 DOI: 10.1586/Eri.11.177 |
0.343 |
|
| 2012 |
Leal MC, Surace EI, Holgado MP, Ferrari CC, Tarelli R, Pitossi F, Wisniewski T, Castaño EM, Morelli L. Notch signaling proteins HES-1 and Hey-1 bind to insulin degrading enzyme (IDE) proximal promoter and repress its transcription and activity: implications for cellular Aβ metabolism. Biochimica Et Biophysica Acta. 1823: 227-35. PMID 22036964 DOI: 10.1016/J.Bbamcr.2011.09.014 |
0.371 |
|
| 2012 |
Ge Y, Zhou Y, Wisniewski T, Li Y, Newman K, Leon MD. 7 Tesla MR susceptibility-contrast microscopy imaging of amyloid pathology and the hippocampus in Alzheimer's disease Alzheimers & Dementia. 8: 699. DOI: 10.1016/J.Jalz.2012.05.1884 |
0.41 |
|
| 2012 |
Goni F, Wong K, Scholtzova H, Sun Y, Pan J, Li J, Ji Y, Wisniewski T. Active immunomodulation targeting abnormal conformation for the treatment of multiple neurodegenerative diseases Alzheimers & Dementia. 8: 625. DOI: 10.1016/J.Jalz.2012.05.1665 |
0.313 |
|
| 2012 |
Scholtzova H, Goni F, Pan J, Sun Y, Li J, Mehta P, Wisniewski T. Innate immunity stimulation as a novel therapeutic approach in Alzheimer's disease Alzheimers & Dementia. 8: 392. DOI: 10.1016/J.Jalz.2012.05.1078 |
0.445 |
|
| 2011 |
Chung E, Prelli F, Dealler S, Lee WS, Chang YT, Wisniewski T. Styryl-based and tricyclic compounds as potential anti-prion agents. Plos One. 6: e24844. PMID 21931860 DOI: 10.1371/Journal.Pone.0024844 |
0.6 |
|
| 2011 |
Yang J, Wadghiri YZ, Hoang DM, Tsui W, Sun Y, Chung E, Li Y, Wang A, de Leon M, Wisniewski T. Detection of amyloid plaques targeted by USPIO-Aβ1-42 in Alzheimer's disease transgenic mice using magnetic resonance microimaging. Neuroimage. 55: 1600-9. PMID 21255656 DOI: 10.1016/J.Neuroimage.2011.01.023 |
0.658 |
|
| 2011 |
Yang J, Ji Y, Mehta P, Bates KA, Sun Y, Wisniewski T. Blocking the apolipoprotein E/amyloid-β interaction reduces fibrillar vascular amyloid deposition and cerebral microhemorrhages in TgSwDI mice. Journal of Alzheimer's Disease : Jad. 24: 269-85. PMID 21239853 DOI: 10.3233/Jad-2011-101401 |
0.476 |
|
| 2011 |
Wegiel J, Kaczmarski W, Barua M, Kuchna I, Nowicki K, Wang KC, Wegiel J, Yang SM, Frackowiak J, Mazur-Kolecka B, Silverman WP, Reisberg B, Monteiro I, de Leon M, Wisniewski T, et al. Link between DYRK1A overexpression and several-fold enhancement of neurofibrillary degeneration with 3-repeat tau protein in Down syndrome. Journal of Neuropathology and Experimental Neurology. 70: 36-50. PMID 21157379 DOI: 10.1097/Nen.0B013E318202Bfa1 |
0.37 |
|
| 2011 |
Goni F, Scholtzova H, Wong K, Sun Y, Pan J, Li J, Ji Y, Wisniewski T. Conformation directed immunomodulation targeting amyloid plaques, CAA and neurofibrillary tangle pathology in model mice Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.09.143 |
0.409 |
|
| 2011 |
Scholtzova H, Goni F, Sun Y, Hatos L, Pan J, Kascsak R, Mehta P, Spinner D, Wisniewski T. Induction of TLR9 signaling in 3xTg-AD mice Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.1912 |
0.336 |
|
| 2010 |
Wisniewski T, Goñi F. Immunomodulation for prion and prion-related diseases. Expert Review of Vaccines. 9: 1441-52. PMID 21105779 DOI: 10.1586/Erv.10.131 |
0.379 |
|
| 2010 |
Goñi F, Prelli F, Ji Y, Scholtzova H, Yang J, Sun Y, Liang FX, Kascsak R, Kascsak R, Mehta P, Wisniewski T. Immunomodulation targeting abnormal protein conformation reduces pathology in a mouse model of Alzheimer's disease. Plos One. 5: e13391. PMID 20967130 DOI: 10.1371/Journal.Pone.0013391 |
0.496 |
|
| 2010 |
Chung E, Ji Y, Sun Y, Kascsak RJ, Kascsak RB, Mehta PD, Strittmatter SM, Wisniewski T. Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an Alzheimer's disease model mouse. Bmc Neuroscience. 11: 130. PMID 20946660 DOI: 10.1186/1471-2202-11-130 |
0.638 |
|
| 2010 |
Wisniewski T, Sigurdsson EM. Murine models of Alzheimer's disease and their use in developing immunotherapies. Biochimica Et Biophysica Acta. 1802: 847-59. PMID 20471477 DOI: 10.1016/J.Bbadis.2010.05.004 |
0.477 |
|
| 2010 |
Wisniewski T, Boutajangout A. Vaccination as a therapeutic approach to Alzheimer's disease. The Mount Sinai Journal of Medicine, New York. 77: 17-31. PMID 20101719 DOI: 10.1002/Msj.20156 |
0.472 |
|
| 2010 |
Wisniewski T, Boutajangout A. Immunotherapeutic approaches for Alzheimer's disease in transgenic mouse models. Brain Structure & Function. 214: 201-18. PMID 20012091 DOI: 10.1007/S00429-009-0236-2 |
0.474 |
|
| 2010 |
Yang J, Scholtzova H, Ji Y, Sun Y, Wisniewski T. Blocking Aβ/Chaperone Interactions to Prevent CAA Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.08.078 |
0.336 |
|
| 2010 |
Goldstein LE, Moir RD, Mocofanescu A, Fu L, Lu S, Burton MA, Xu W, Ericsson M, Rogers J, Chadwick O, Sadowski M, Wisniewski T, Klunk WE, Mathis CA, Clark JI, et al. P4-011: In vivo Detection of Early Alzheimer's Disease-Linked Aβ Peptide Accumulation in the Lens by Non-Invasive Quasi-Elastic Light Scattering Alzheimer's & Dementia. 6: e23-e23. DOI: 10.1016/J.Jalz.2010.08.071 |
0.374 |
|
| 2010 |
Chung E, Prelli F, Yeoun D, Chang Y, Wisniewski T. Treatment of prion infection in vitro and in vivo Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.424 |
0.527 |
|
| 2010 |
Goni F, Prelli F, Kascsak R, Kascsak R, Wisniewski T. Development of conformational monoclonal antibodies that detects multiple amyloid proteins Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.2006 |
0.324 |
|
| 2010 |
Wisniewski T, Chung E, Ji Y, Sun Y, Kascsak R, Kascsak R, Strittmatter SM. Anti-PrPC monoclonal antibody infusion as a novel treatment for Aß oligomer cognitive deficits Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.2004 |
0.638 |
|
| 2010 |
Scholtzova H, Ji Y, Goni F, Sun Y, Kascsak R, Mehta PD, Spinner DS, Wisniewski T. Stimulation of innate immunity via Toll-like receptor 9 mitigates Alzheimer pathology Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.1913 |
0.306 |
|
| 2010 |
Yang J, Hoang MD, Wadghiri YZ, Wisniewski T. Detection of amyloid plaques in Alzheimer's transgenic mice using contrast-enhanced magentic resonance microimaging Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.1406 |
0.406 |
|
| 2009 |
Boutajangout A, Goni F, Knudsen E, Schreiber F, Asuni A, Quartermain D, Frangione B, Chabalgoity A, Wisniewski T, Sigurdsson EM. Diminished amyloid-beta burden in Tg2576 mice following a prophylactic oral immunization with a salmonella-based amyloid-beta derivative vaccine. Journal of Alzheimer's Disease : Jad. 18: 961-72. PMID 19749432 DOI: 10.3233/Jad-2009-1204 |
0.434 |
|
| 2009 |
Sadowski MJ, Pankiewicz J, Prelli F, Scholtzova H, Spinner DS, Kascsak RB, Kascsak RJ, Wisniewski T. Anti-PrP Mab 6D11 suppresses PrP(Sc) replication in prion infected myeloid precursor line FDC-P1/22L and in the lymphoreticular system in vivo. Neurobiology of Disease. 34: 267-78. PMID 19385058 DOI: 10.1016/J.Nbd.2009.01.013 |
0.339 |
|
| 2009 |
Wisniewski T. AD vaccines: conclusions and future directions. Cns & Neurological Disorders Drug Targets. 8: 160-6. PMID 19355935 DOI: 10.2174/187152709787847289 |
0.435 |
|
| 2009 |
Scholtzova H, Kascsak RJ, Bates KA, Boutajangout A, Kerr DJ, Meeker HC, Mehta PD, Spinner DS, Wisniewski T. Induction of toll-like receptor 9 signaling as a method for ameliorating Alzheimer's disease-related pathology. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 1846-54. PMID 19211891 DOI: 10.1523/Jneurosci.5715-08.2009 |
0.463 |
|
| 2009 |
Trouche SG, Asuni A, Rouland S, Wisniewski T, Frangione B, Verdier JM, Sigurdsson EM, Mestre-Francés N. Antibody response and plasma Abeta1-40 levels in young Microcebus murinus primates immunized with Abeta1-42 and its derivatives. Vaccine. 27: 957-64. PMID 19114076 DOI: 10.1016/J.Vaccine.2008.12.012 |
0.381 |
|
| 2009 |
Zhan J, Brys M, Glodzik L, Tsui W, Javier E, Wegiel J, Kuchna I, Pirraglia E, Li Y, Mosconi L, Saint Louis LA, Switalski R, De Santi S, Kim BC, Wisniewski T, et al. An entorhinal cortex sulcal pattern is associated with Alzheimer's disease. Human Brain Mapping. 30: 874-82. PMID 18381771 DOI: 10.1002/Hbm.20549 |
0.365 |
|
| 2009 |
Goni F, Estevez V, Yim L, Sun Y, Chung E, Carp R, Meeker C, Rubenstein R, Chabalgoity A, Wisniewski T. Mucosal vaccination of elk-PrP transgenic mice to prevent prion transmission via an oral route Alzheimers & Dementia. 5. DOI: 10.1016/J.Jalz.2009.07.138 |
0.558 |
|
| 2009 |
Scholtzova H, Kascsak RJ, Bates KA, Boutajangout A, Kerr DJ, Meeker HC, Mehta PD, Spinner DS, Wisniewski T. Toll-like receptor 9 ligand CpG ODN as a new highly effective agent for prevention and/or treatment of Alzheimer's disease Alzheimers & Dementia. 5. DOI: 10.1016/J.Jalz.2009.05.467 |
0.325 |
|
| 2009 |
Wisniewski T, Prelli F, Scholtzova H, Chung E, Mehta PD, Kascsak R, Kascsak R, Goni F. Immunotherapy targeting abnormal protein conformation Alzheimers & Dementia. 5: 113. DOI: 10.1016/J.Jalz.2009.05.354 |
0.537 |
|
| 2009 |
Boutajangout A, Frangione B, Wisniewski T, Brion J, Sigurdsson EM. P4-049: Influence of presenilin mutation on tau pathology in a novel Alzheimer's disease mouse model Alzheimer's & Dementia. 5: P445-P446. DOI: 10.1016/J.Jalz.2009.04.919 |
0.404 |
|
| 2008 |
Wisniewski T, Sadowski M. Preventing beta-amyloid fibrillization and deposition: beta-sheet breakers and pathological chaperone inhibitors. Bmc Neuroscience. 9: S5. PMID 19090993 DOI: 10.1186/1471-2202-9-S2-S5 |
0.466 |
|
| 2008 |
Cercy SP, Sadowski MJ, Wisniewski T. Prominent neuroleptic sensitivity in a case of early-onset Alzheimer disease due to presenilin-1 G206A mutation. Cognitive and Behavioral Neurology : Official Journal of the Society For Behavioral and Cognitive Neurology. 21: 190-5. PMID 18797263 DOI: 10.1097/Wnn.0B013E31817D74Bf |
0.328 |
|
| 2008 |
Spinner DS, Cho IS, Park SY, Kim JI, Meeker HC, Ye X, Lafauci G, Kerr DJ, Flory MJ, Kim BS, Kascsak RB, Wisniewski T, Levis WR, Schuller-Levis GB, Carp RI, et al. Accelerated prion disease pathogenesis in Toll-like receptor 4 signaling-mutant mice. Journal of Virology. 82: 10701-8. PMID 18715916 DOI: 10.1128/Jvi.00522-08 |
0.311 |
|
| 2008 |
Wegiel J, Dowjat K, Kaczmarski W, Kuchna I, Nowicki K, Frackowiak J, Mazur Kolecka B, Wegiel J, Silverman WP, Reisberg B, Deleon M, Wisniewski T, Gong CX, Liu F, Adayev T, et al. The role of overexpressed DYRK1A protein in the early onset of neurofibrillary degeneration in Down syndrome. Acta Neuropathologica. 116: 391-407. PMID 18696092 DOI: 10.1007/S00401-008-0419-6 |
0.372 |
|
| 2008 |
Wisniewski T, Konietzko U. Amyloid-beta immunisation for Alzheimer's disease. The Lancet. Neurology. 7: 805-11. PMID 18667360 DOI: 10.1016/S1474-4422(08)70170-4 |
0.444 |
|
| 2008 |
Scholtzova H, Wadghiri YZ, Douadi M, Sigurdsson EM, Li YS, Quartermain D, Banerjee P, Wisniewski T. Memantine leads to behavioral improvement and amyloid reduction in Alzheimer's-disease-model transgenic mice shown as by micromagnetic resonance imaging. Journal of Neuroscience Research. 86: 2784-91. PMID 18615702 DOI: 10.1002/Jnr.21713 |
0.441 |
|
| 2008 |
Gambetti P, Dong Z, Yuan J, Xiao X, Zheng M, Alshekhlee A, Castellani R, Cohen M, Barria MA, Gonzalez-Romero D, Belay ED, Schonberger LB, Marder K, Harris C, Burke JR, ... ... Wisniewski T, et al. A novel human disease with abnormal prion protein sensitive to protease. Annals of Neurology. 63: 697-708. PMID 18571782 DOI: 10.1002/Ana.21420 |
0.364 |
|
| 2008 |
Klyubin I, Betts V, Welzel AT, Blennow K, Zetterberg H, Wallin A, Lemere CA, Cullen WK, Peng Y, Wisniewski T, Selkoe DJ, Anwyl R, Walsh DM, Rowan MJ. Amyloid beta protein dimer-containing human CSF disrupts synaptic plasticity: prevention by systemic passive immunization. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 4231-7. PMID 18417702 DOI: 10.1523/Jneurosci.5161-07.2008 |
0.415 |
|
| 2008 |
Goñi F, Prelli F, Schreiber F, Scholtzova H, Chung E, Kascsak R, Brown DR, Sigurdsson EM, Chabalgoity JA, Wisniewski T. High titers of mucosal and systemic anti-PrP antibodies abrogate oral prion infection in mucosal-vaccinated mice. Neuroscience. 153: 679-86. PMID 18407424 DOI: 10.1016/J.Neuroscience.2008.02.051 |
0.597 |
|
| 2008 |
Firuzi O, Zhuo J, Chinnici CM, Wisniewski T, Praticò D. 5-Lipoxygenase gene disruption reduces amyloid-beta pathology in a mouse model of Alzheimer's disease. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 22: 1169-78. PMID 17998412 DOI: 10.1096/Fj.07-9131.Com |
0.438 |
|
| 2008 |
Sigurdsson EM, Wadghiri YZ, Mosconi L, Blind JA, Knudsen E, Asuni A, Scholtzova H, Tsui WH, Li Y, Sadowski M, Turnbull DH, de Leon MJ, Wisniewski T. A non-toxic ligand for voxel-based MRI analysis of plaques in AD transgenic mice. Neurobiology of Aging. 29: 836-47. PMID 17291630 DOI: 10.1016/J.Neurobiolaging.2006.12.018 |
0.405 |
|
| 2008 |
Moncaster JA, Moir RD, Mocofanescu AG, Burton MA, Ghosh J, Ericsson M, Rogers JT, Klunk WE, Mathis CA, Sadowski M, Wisniewski T, Clark JI, Tanzi RE, Goldstein LE. P1-379: In vivo detection of Alzheimer's disease–linked Aβ peptide accumulation in the lens Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.961 |
0.384 |
|
| 2008 |
Trouche SG, Asuni A, Boutajangout A, Frangione B, Wisniewski T, Rouland S, Verdier J, Sigurdsson EM, Mestre-Frances N. P1-021: Neuropathological evaluation of the nonhuman primate
microcebus murinus
immunized with K6Aβ1-30, an Aβ derivative peptide Alzheimer's & Dementia. 4: T211-T211. DOI: 10.1016/J.Jalz.2008.05.606 |
0.327 |
|
| 2008 |
Boutajangout A, Frangione B, Brion J, Wisniewski T, Sigurdsson EM. O4-01-05: Presenilin 1 mutation promotes Tau phosphorylation and aggregation in a novel Alzheimer's disease mouse model Alzheimer's & Dementia. 4: T185-T185. DOI: 10.1016/J.Jalz.2008.05.504 |
0.403 |
|
| 2008 |
Scholtzova H, Kascsak RJ, Kerr DJ, Marchi EJ, Boutajangout A, Chung E, Quartermain D, Spinner DS, Wisniewski T. P2-405: Induction of toll-like receptor 9 signaling as a method for preventing or ameliorating Alzheimer's disease Alzheimer's & Dementia. 4: T492-T492. DOI: 10.1016/J.Jalz.2008.05.1484 |
0.547 |
|
| 2008 |
Sadowski MJ, Pulyk R, Poon SY, Pankiewicz JE, Scholtzova H, Quartermain D, Wisniewski T. P1-441: Increased parenchymal and vascular Aβ deposition in Alzheimer's disease transgenic mice with chronic hyperglycemia Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.1023 |
0.423 |
|
| 2007 |
Li Q, Min J, Ahn YH, Namm J, Kim EM, Lui R, Kim HY, Ji Y, Wu H, Wisniewski T, Chang YT. Styryl-based compounds as potential in vivo imaging agents for beta-amyloid plaques. Chembiochem : a European Journal of Chemical Biology. 8: 1679-87. PMID 17705341 DOI: 10.1002/Cbic.200700154 |
0.404 |
|
| 2007 |
Webb S, Lekishvili T, Loeschner C, Sellarajah S, Prelli F, Wisniewski T, Gilbert IH, Brown DR. Mechanistic insights into the cure of prion disease by novel antiprion compounds. Journal of Virology. 81: 10729-41. PMID 17652397 DOI: 10.1128/Jvi.01075-07 |
0.344 |
|
| 2007 |
Sadowski M, Wisniewski T. Disease modifying approaches for Alzheimer's pathology. Current Pharmaceutical Design. 13: 1943-54. PMID 17627527 DOI: 10.2174/138161207781039788 |
0.477 |
|
| 2007 |
Wisniewski T, Sigurdsson EM. Therapeutic approaches for prion and Alzheimer's diseases. The Febs Journal. 274: 3784-98. PMID 17617224 DOI: 10.1111/J.1742-4658.2007.05919.X |
0.38 |
|
| 2007 |
Spinner DS, Kascsak RB, Lafauci G, Meeker HC, Ye X, Flory MJ, Kim JI, Schuller-Levis GB, Levis WR, Wisniewski T, Carp RI, Kascsak RJ. CpG oligodeoxynucleotide-enhanced humoral immune response and production of antibodies to prion protein PrPSc in mice immunized with 139A scrapie-associated fibrils. Journal of Leukocyte Biology. 81: 1374-85. PMID 17379700 DOI: 10.1189/Jlb.1106665 |
0.314 |
|
| 2007 |
Wegiel J, Kuchna I, Nowicki K, Frackowiak J, Mazur-Kolecka B, Imaki H, Wegiel J, Mehta PD, Silverman WP, Reisberg B, Deleon M, Wisniewski T, Pirttilla T, Frey H, Lehtimäki T, et al. Intraneuronal Abeta immunoreactivity is not a predictor of brain amyloidosis-beta or neurofibrillary degeneration. Acta Neuropathologica. 113: 389-402. PMID 17237937 DOI: 10.1007/S00401-006-0191-4 |
0.381 |
|
| 2007 |
Chang B, Cheng X, Yin S, Pan T, Zhang H, Wong P, Kang SC, Xiao F, Yan H, Li C, Wolfe LL, Miller MW, Wisniewski T, Greene MI, Sy MS. Test for detection of disease-associated prion aggregate in the blood of infected but asymptomatic animals. Clinical and Vaccine Immunology : Cvi. 14: 36-43. PMID 17079434 DOI: 10.1128/Cvi.00341-06 |
0.354 |
|
| 2007 |
Banerjee P, Tanila H, Wisniewski T, Gupta S, LaFerla F, Lahiri DK. P-188: Memantine lowers amyloid beta levels in neuronal cells and transgenic mouse models of Alzheimer's disease Alzheimer's & Dementia. 3: S158-S158. DOI: 10.1016/J.Jalz.2007.04.151 |
0.408 |
|
| 2007 |
Moncaster J, Moir RD, Fu L, Mocofanescu A, Lu S, Xu W, Chadwick O, Rogers JT, Sadowski M, Wisniewski T, Klunk WE, Mathis CA, Clark JI, Tanzi RE, Goldstein LE. O2-03-05: Early detection of Alzheimer's disease-linked aβ peptide accumulation in the lens by non-invasive quasi-elastic light scattering Alzheimer's & Dementia. 3: S190-S190. DOI: 10.1016/J.Jalz.2007.04.030 |
0.353 |
|
| 2006 |
Sadowski MJ, Pankiewicz J, Scholtzova H, Mehta PD, Prelli F, Quartermain D, Wisniewski T. Blocking the apolipoprotein E/amyloid-beta interaction as a potential therapeutic approach for Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. 103: 18787-92. PMID 17116874 DOI: 10.1073/Pnas.0604011103 |
0.439 |
|
| 2006 |
Asuni AA, Boutajangout A, Scholtzova H, Knudsen E, Li YS, Quartermain D, Frangione B, Wisniewski T, Sigurdsson EM. Vaccination of Alzheimer's model mice with Abeta derivative in alum adjuvant reduces Abeta burden without microhemorrhages. The European Journal of Neuroscience. 24: 2530-42. PMID 17100841 DOI: 10.1111/J.1460-9568.2006.05149.X |
0.425 |
|
| 2006 |
Leal MC, Dorfman VB, Gamba AF, Frangione B, Wisniewski T, Castaño EM, Sigurdsson EM, Morelli L. Plaque-associated overexpression of insulin-degrading enzyme in the cerebral cortex of aged transgenic tg2576 mice with Alzheimer pathology. Journal of Neuropathology and Experimental Neurology. 65: 976-87. PMID 17021402 DOI: 10.1097/01.Jnen.0000235853.70092.Ba |
0.417 |
|
| 2006 |
Pankiewicz J, Prelli F, Sy MS, Kascsak RJ, Kascsak RB, Spinner DS, Carp RI, Meeker HC, Sadowski M, Wisniewski T. Clearance and prevention of prion infection in cell culture by anti-PrP antibodies. The European Journal of Neuroscience. 23: 2635-47. PMID 16817866 DOI: 10.1111/J.1460-9568.2006.04805.X |
0.305 |
|
| 2006 |
Scholtzova H, Wadghiri YZ, Sigurdsson EM, Douadi M, Li Y, Quartermain D, Banerjee PK, Wisniewski T. P.5.b.003 Assessing the effects of memantine in APP/PS1 transgenic mice by behavioural studies and ex vivo imaging of amyloid plaques using gadolinium labelled amyloid β peptides and μMRI European Neuropsychopharmacology. 16. DOI: 10.1016/S0924-977X(06)70645-9 |
0.389 |
|
| 2006 |
Wisniewski T, Scholtzova H, Wadghiri YZ, Sigurdsson EM, Douadi M, Li Y, Quartermain D, Banerjee PK. P1-104: Assessing the effects of memantine in APP/PS1 transgenic mice by behavioral studies and ex vivo imaging of amyloid plaques using gadolinium labeled amyloid β peptides and micromri Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.480 |
0.39 |
|
| 2006 |
Boutajangout A, Asuni AA, Scholtzova H, Knudsen E, Li Y, Quartermain D, Frangione B, Wisniewski T, Sigurdsson EM. P4-316: Aβ derivative vaccine does not cause brain microhemorrhages in Tg2576 mice and its effectiveness is age-dependent Alzheimer's & Dementia. 2: S609-S610. DOI: 10.1016/J.Jalz.2006.05.2057 |
0.344 |
|
| 2006 |
Trouche S, Asuni A, Wisniewski T, Frangione B, Sigurdsson E, Verdier J, Mestre-Frances N. P4-290: Immunization with Aβ derivatives in Microcebus murinus
: A primate lemurian model of Alzheimer's disease Alzheimer's & Dementia. 2: S602-S602. DOI: 10.1016/J.Jalz.2006.05.2029 |
0.421 |
|
| 2006 |
Prelli F, Pankiewicz J, Moncaster J, Klunk W, Carp R, Meeker H, Sadowski M, Goldstein LE, Wisniewski T. P4-123: PrPSc Aggregates in the ocular lens of symptomatic and pre-symptomatic prion infected mice Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.1862 |
0.315 |
|
| 2006 |
Leal MC, Dorfman VB, Fernandez Gamba AC, Frangione B, Wisniewski T, Castaño EM, Sigurdsson EM, Morelli L. P4-075: Fibrillar Aβ triggers insulin degrading enzyme (IDE) over-expression by glial cells in old Tg2576 mice Alzheimer's & Dementia. 2: S535-S536. DOI: 10.1016/J.Jalz.2006.05.1813 |
0.304 |
|
| 2006 |
Wu H, Ji Y, Scholtzova H, Li Q, Sadowski M, Gan W, Chang Y, Wisniewski T. AbstractPoster presentation: Monday posterP2-325: In VIVO labeling of amyloid β plaques in AD model mice using blood-brain barrier permeable styryl dyes Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.1165 |
0.406 |
|
| 2005 |
Pan T, Chang B, Wong P, Li C, Li R, Kang SC, Robinson JD, Thompsett AR, Tein P, Yin S, Barnard G, McConnell I, Brown DR, Wisniewski T, Sy MS. An aggregation-specific enzyme-linked immunosorbent assay: detection of conformational differences between recombinant PrP protein dimers and PrP(Sc) aggregates. Journal of Virology. 79: 12355-64. PMID 16160162 DOI: 10.1128/Jvi.79.19.12355-12364.2005 |
0.365 |
|
| 2005 |
Wadghiri YZ, Sigurdsson EM, Wisniewski T, Turnbull DH. Magnetic resonance imaging of amyloid plaques in transgenic mice. Methods in Molecular Biology (Clifton, N.J.). 299: 365-79. PMID 15980617 DOI: 10.1385/1-59259-874-9:365 |
0.354 |
|
| 2005 |
Goñi F, Knudsen E, Schreiber F, Scholtzova H, Pankiewicz J, Carp R, Meeker HC, Rubenstein R, Brown DR, Sy MS, Chabalgoity JA, Sigurdsson EM, Wisniewski T. Mucosal vaccination delays or prevents prion infection via an oral route. Neuroscience. 133: 413-21. PMID 15878645 DOI: 10.1016/J.Neuroscience.2005.02.031 |
0.317 |
|
| 2005 |
Sassoon J, Sadowski M, Wisniewski T, Brown DR. Therapeutics and prion disease: can immunisation or drugs be effective? Mini Reviews in Medicinal Chemistry. 5: 361-6. PMID 15853626 DOI: 10.2174/1389557053544065 |
0.324 |
|
| 2005 |
Wisniewski T, Frangione B. Immunological and anti-chaperone therapeutic approaches for Alzheimer disease. Brain Pathology (Zurich, Switzerland). 15: 72-7. PMID 15779239 DOI: 10.1111/J.1750-3639.2005.Tb00102.X |
0.452 |
|
| 2005 |
Wisniewski T. Is amyloid-β-peptide immunization clinically effective in patients with Alzheimer's disease? Nature Reviews Neurology. 1: 84-85. DOI: 10.1038/Ncpneuro0019 |
0.394 |
|
| 2005 |
Sigurdsson E, Wadghiri Y, Knudsen E, Asuni A, Sadowski M, Turnbull D, Wisniewski T. [O1-03-05]: In vivo detection of amyloid plaques in AD transgenic mice using gadolinium labeled ligands by MRI Alzheimer's & Dementia. 1: S84-S84. DOI: 10.1016/J.Jalz.2005.06.296 |
0.368 |
|
| 2005 |
Sadowski M, Pankiewicz J, Scholtzova H, Wen P, Mehta P, Wisniewski T. Blocking the apolipoprotein E/amyloid-B interaction reduces amyloid-B load in AD transgenic mice Alzheimers & Dementia. 1. DOI: 10.1016/J.Jalz.2005.06.243 |
0.375 |
|
| 2004 |
Ghiso J, Wisniewski T. An animal model of vascular amyloidosis. Nature Neuroscience. 7: 902-4. PMID 15332087 DOI: 10.1038/Nn0904-902 |
0.431 |
|
| 2004 |
Sadowski M, Pankiewicz J, Scholtzova H, Ripellino JA, Li Y, Schmidt SD, Mathews PM, Fryer JD, Holtzman DM, Sigurdsson EM, Wisniewski T. A synthetic peptide blocking the apolipoprotein E/beta-amyloid binding mitigates beta-amyloid toxicity and fibril formation in vitro and reduces beta-amyloid plaques in transgenic mice. The American Journal of Pathology. 165: 937-48. PMID 15331417 DOI: 10.1016/S0002-9440(10)63355-X |
0.434 |
|
| 2004 |
Sadowski M, Pankiewicz J, Scholtzova H, Tsai J, Li Y, Carp RI, Meeker HC, Gambetti P, Debnath M, Mathis CA, Shao L, Gan WB, Klunk WE, Wisniewski T. Targeting prion amyloid deposits in vivo. Journal of Neuropathology and Experimental Neurology. 63: 775-84. PMID 15290902 DOI: 10.1093/Jnen/63.7.775 |
0.436 |
|
| 2004 |
Sigurdsson EM, Knudsen E, Asuni A, Fitzer-Attas C, Sage D, Quartermain D, Goni F, Frangione B, Wisniewski T. An attenuated immune response is sufficient to enhance cognition in an Alzheimer's disease mouse model immunized with amyloid-beta derivatives. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 6277-82. PMID 15254082 DOI: 10.1523/Jneurosci.1344-04.2004 |
0.445 |
|
| 2004 |
Sadowski M, Pankiewicz J, Scholtzova H, Ji Y, Quartermain D, Jensen CH, Duff K, Nixon RA, Gruen RJ, Wisniewski T. Amyloid-beta deposition is associated with decreased hippocampal glucose metabolism and spatial memory impairment in APP/PS1 mice. Journal of Neuropathology and Experimental Neurology. 63: 418-28. PMID 15198121 DOI: 10.1093/Jnen/63.5.418 |
0.371 |
|
| 2004 |
Sadowski M, Wisniewski T. Vaccines for conformational disorders. Expert Review of Vaccines. 3: 279-90. PMID 15176944 DOI: 10.1586/14760584.3.3.279 |
0.391 |
|
| 2004 |
Sadowski M, Pankiewicz J, Scholtzova H, Li YS, Quartermain D, Duff K, Wisniewski T. Links between the pathology of Alzheimer's disease and vascular dementia. Neurochemical Research. 29: 1257-66. PMID 15176482 DOI: 10.1023/B:Nere.0000023612.66691.E6 |
0.437 |
|
| 2004 |
Kang SC, Brown DR, Whiteman M, Li R, Pan T, Perry G, Wisniewski T, Sy MS, Wong BS. Prion protein is ubiquitinated after developing protease resistance in the brains of scrapie-infected mice. The Journal of Pathology. 203: 603-8. PMID 15095484 DOI: 10.1002/Path.1555 |
0.324 |
|
| 2004 |
Helpern JA, Lee SP, Falangola MF, Dyakin VV, Bogart A, Ardekani B, Duff K, Branch C, Wisniewski T, de Leon MJ, Wolf O, O'Shea J, Nixon RA. MRI assessment of neuropathology in a transgenic mouse model of Alzheimer's disease. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 51: 794-8. PMID 15065253 DOI: 10.1002/Mrm.20038 |
0.453 |
|
| 2004 |
Dowjat WK, Kuchna I, Wisniewski T, Wegiel J. A novel highly pathogenic Alzheimer presenilin-1 mutation in codon 117 (Pro117Ser): Comparison of clinical, neuropathological and cell culture phenotypes of Pro117Leu and Pro117Ser mutations. Journal of Alzheimer's Disease : Jad. 6: 31-43. PMID 15004326 DOI: 10.3233/Jad-2004-6105 |
0.322 |
|
| 2004 |
Wisniewski T, Pankiewicz J, Scholtzova H, Schmidt SD, Mathews PM, Sigurdsson EM, Sadowski M. P4-381 Reduction of β-amyloid load in Alzheimer's disease transgenic mice by competitive blocking of β-amyloid binding to apolipoprotein E Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)81939-0 |
0.406 |
|
| 2004 |
Asuni AA, Knudsen E, Frangione B, Wisniewski T, Sigurdsson EM. P4-375 Antibody mediated modulation of Aβ induced neurotoxicity in cell culture Neurobiology of Aging. 25: S581-S582. DOI: 10.1016/S0197-4580(04)81933-X |
0.309 |
|
| 2004 |
Sigurdsson EM, Knudsen E, Asuni A, Sage D, Goni F, Quartermain D, Frangione B, Wisniewski T. P4-357 Modest immune response elicited by Aβ derivatives in TG2576 mice improves cognition Neurobiology of Aging. 25: S576. DOI: 10.1016/S0197-4580(04)81915-8 |
0.331 |
|
| 2004 |
Kuchna I, Nowicki K, Imaki H, Wang K, Mehta PD, Silverman WP, Reisberg B, Leon Md, Wisniewski T, Pirttila T, Frey H, Lehtimaki T, Kivimaki T, Visser FE, Kamphorst W, et al. P3-182 Intraneuronal amyloid beta immunoreactivity is not a predictor of fibrillar plaque formation or neurofibrillary degeneration Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)81334-4 |
0.367 |
|
| 2004 |
Sadowski M, Pankiewicz J, Scholtzova H, Tsai J, Carp RI, Meeker HC, Debnath M, Mathis CA, Shao L, Klunk WE, Gan W, Wisniewski T. P2-186 In vivo imaging of prion amyloid deposits Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)80932-1 |
0.339 |
|
| 2004 |
Scholtzova H, Pankiewicz J, Sadowski M, Quartermain D, Jensen CH, Duff K, Nixon RA, Helpern JH, Gruen RJ, Wisniewski T. P2-007 Age-associated behavioral, metabolic, and structural changes in wild-type littermates of Alzheimer's transgenic mice Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)80755-3 |
0.333 |
|
| 2004 |
Sigurdsson EM, Wadghiri YZ, Blind JA, Knudsen E, Asuni AA, Sadowski M, Turnbull DH, Wisniewski T. O3-03-03 In vivo magnetic resonance imaging of amyloid plaques in mice with a non-toxic Aβ derivative Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)80193-3 |
0.352 |
|
| 2004 |
Wisniewski T, Pankiewicz J, Scholtzova H, Fernando G, Chabalgoity JA, Ji Y, Wadghiri YZ, Gan W, Tang CY, Turnbull DH, Mathis CA, Kascsak R, Klunk WE, Carp RI, Frangione B, et al. S2-04-04 Imaging and therapeutic approaches for β-sheet structures in prion and Alzheimer's diseases Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)80100-3 |
0.354 |
|
| 2003 |
Ji Y, Gong Y, Gan W, Beach T, Holtzman DM, Wisniewski T. Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer's disease patients. Neuroscience. 122: 305-15. PMID 14614898 DOI: 10.1016/J.Neuroscience.2003.08.007 |
0.372 |
|
| 2003 |
Sigurdsson EM, Brown DR, Alim MA, Scholtzova H, Carp R, Meeker HC, Prelli F, Frangione B, Wisniewski T. Copper chelation delays the onset of prion disease. The Journal of Biological Chemistry. 278: 46199-202. PMID 14519758 DOI: 10.1074/Jbc.C300303200 |
0.316 |
|
| 2003 |
Wadghiri YZ, Sigurdsson EM, Sadowski M, Elliott JI, Li Y, Scholtzova H, Tang CY, Aguinaldo G, Pappolla M, Duff K, Wisniewski T, Turnbull DH. Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 50: 293-302. PMID 12876705 DOI: 10.1002/Mrm.10529 |
0.427 |
|
| 2003 |
Sigurdsson EM, Sy MS, Li R, Scholtzova H, Kascsak RJ, Kascsak R, Carp R, Meeker HC, Frangione B, Wisniewski T. Anti-prion antibodies for prophylaxis following prion exposure in mice. Neuroscience Letters. 336: 185-7. PMID 12505623 DOI: 10.1016/S0304-3940(02)01192-8 |
0.362 |
|
| 2002 |
Mackic JB, Bading J, Ghiso J, Walker L, Wisniewski T, Frangione B, Zlokovic BV. Circulating amyloid-beta peptide crosses the blood-brain barrier in aged monkeys and contributes to Alzheimer's disease lesions. Vascular Pharmacology. 38: 303-13. PMID 12529925 DOI: 10.1016/S1537-1891(02)00198-2 |
0.314 |
|
| 2002 |
Poduslo JF, Wengenack TM, Curran GL, Wisniewski T, Sigurdsson EM, Macura SI, Borowski BJ, Jack CR. Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging. Neurobiology of Disease. 11: 315-29. PMID 12505424 DOI: 10.1006/Nbdi.2002.0550 |
0.38 |
|
| 2002 |
Sigurdsson EM, Wisniewski T, Frangione B. A safer vaccine for Alzheimer's disease? Neurobiology of Aging. 23: 1001-8. PMID 12470795 DOI: 10.1016/S0197-4580(02)00124-0 |
0.45 |
|
| 2002 |
de Leon MJ, Segal S, Tarshish CY, DeSanti S, Zinkowski R, Mehta PD, Convit A, Caraos C, Rusinek H, Tsui W, Saint Louis LA, DeBernardis J, Kerkman D, Qadri F, Gary A, ... ... Wisniewski T, et al. Longitudinal cerebrospinal fluid tau load increases in mild cognitive impairment. Neuroscience Letters. 333: 183-6. PMID 12429378 DOI: 10.1016/S0304-3940(02)01038-8 |
0.414 |
|
| 2002 |
Sigurdsson EM, Wisniewski T, Frangione B. Infectivity of amyloid diseases. Trends in Molecular Medicine. 8: 411-3. PMID 12223307 DOI: 10.1016/S1471-4914(02)02403-6 |
0.443 |
|
| 2002 |
Wisniewski T, Brown DR, Sigurdsson EM. Therapeutics in Alzheimer's and prion diseases. Biochemical Society Transactions. 30: 574-8. PMID 12196140 DOI: 10.1042/Bst0300574 |
0.392 |
|
| 2002 |
Wisniewski T, Sigurdsson EM. Immunization treatment approaches in Alzheimer's and prion diseases. Current Neurology and Neuroscience Reports. 2: 400-4. PMID 12169219 DOI: 10.1007/S11910-002-0065-7 |
0.444 |
|
| 2002 |
Sigurdsson EM, Brown DR, Daniels M, Kascsak RJ, Kascsak R, Carp R, Meeker HC, Frangione B, Wisniewski T. Immunization delays the onset of prion disease in mice. The American Journal of Pathology. 161: 13-7. PMID 12107084 DOI: 10.1016/S0002-9440(10)64151-X |
0.37 |
|
| 2002 |
Wen PH, Shao X, Shao Z, Hof PR, Wisniewski T, Kelley K, Friedrich VL, Ho L, Pasinetti GM, Shioi J, Robakis NK, Elder GA. Overexpression of wild type but not an FAD mutant presenilin-1 promotes neurogenesis in the hippocampus of adult mice. Neurobiology of Disease. 10: 8-19. PMID 12079399 DOI: 10.1006/Nbdi.2002.0490 |
0.31 |
|
| 2002 |
Wegiel J, Kuchna I, Wisniewski T, de Leon MJ, Reisberg B, Pirttila T, Kivimaki T, Lehtimaki T. Vascular fibrosis and calcification in the hippocampus in aging, Alzheimer disease, and Down syndrome. Acta Neuropathologica. 103: 333-43. PMID 11904752 DOI: 10.1007/S00401-001-0471-Y |
0.348 |
|
| 2002 |
Sigurdsson EM, Frangione B, Wisniewski T. Immunization for Alzheimer's disease Drug Development Research. 56: 135-142. DOI: 10.1002/Ddr.10068 |
0.471 |
|
| 2001 |
Wisniewski T, Sigurdsson EM, Aucouturier P, Frangione B. Conformation as therapeutic target in the prionoses and other neurodegenerative conditions. Methods in Molecular Medicine. 59: 223-36. PMID 21374507 DOI: 10.1385/1-59259-134-5:223 |
0.437 |
|
| 2001 |
Ji Y, Permanne B, Sigurdsson EM, Holtzman DM, Wisniewski T. Amyloid beta40/42 clearance across the blood-brain barrier following intra-ventricular injections in wild-type, apoE knock-out and human apoE3 or E4 expressing transgenic mice. Journal of Alzheimer's Disease : Jad. 3: 23-30. PMID 12214069 DOI: 10.3233/Jad-2001-3105 |
0.427 |
|
| 2001 |
Poeggeler B, Miravalle L, Zagorski MG, Wisniewski T, Chyan YJ, Zhang Y, Shao H, Bryant-Thomas T, Vidal R, Frangione B, Ghiso J, Pappolla MA. Melatonin reverses the profibrillogenic activity of apolipoprotein E4 on the Alzheimer amyloid Abeta peptide. Biochemistry. 40: 14995-5001. PMID 11732920 DOI: 10.1021/Bi0114269 |
0.455 |
|
| 2001 |
Wegiel J, Bobinski M, Tarnawski M, Dziewiatkowski J, Popovitch E, Miller DC, Wisniewski T, Golomb J, de Leon MJ, Reisberg B. Fibrillar amyloid-beta affects neurofibrillary changes but only in neurons already involved in neurofibrillary degeneration. Acta Neuropathologica. 101: 585-90. PMID 11515787 DOI: 10.1007/S004010000334 |
0.389 |
|
| 2001 |
Sigurdsson EM, Scholtzova H, Mehta PD, Frangione B, Wisniewski T. Immunization with a nontoxic/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice. The American Journal of Pathology. 159: 439-47. PMID 11485902 DOI: 10.1016/S0002-9440(10)61715-4 |
0.441 |
|
| 2001 |
Dowjat WK, Wisniewski H, Wisniewski T. Alzheimer's disease presenilin-1 expression modulates the assembly of neurofilaments. Neuroscience. 103: 1-8. PMID 11311782 DOI: 10.1016/S0306-4522(00)00550-9 |
0.37 |
|
| 2000 |
Golabek AA, Kida E, Walus M, Perez C, Wisniewski T, Soto C. Sodium dodecyl sulfate-resistant complexes of Alzheimer's amyloid beta-peptide with the N-terminal, receptor binding domain of apolipoprotein E. Biophysical Journal. 79: 1008-15. PMID 10920030 DOI: 10.1016/S0006-3495(00)76354-5 |
0.305 |
|
| 2000 |
Aucouturier P, Carp RI, Carnaud C, Wisniewski T. Prion diseases and the immune system. Clinical Immunology (Orlando, Fla.). 96: 79-85. PMID 10900153 DOI: 10.1006/Clim.2000.4875 |
0.316 |
|
| 2000 |
Sigurdsson EM, Permanne B, Soto C, Wisniewski T, Frangione B. In vivo reversal of amyloid-beta lesions in rat brain. Journal of Neuropathology and Experimental Neurology. 59: 11-7. PMID 10744031 DOI: 10.1093/Jnen/59.1.11 |
0.404 |
|
| 2000 |
Stoltzner SE, Grenfell TJ, Mori C, Wisniewski KE, Wisniewski TM, Selkoe DJ, Lemere CA. Temporal accrual of complement proteins in amyloid plaques in Down's syndrome with Alzheimer's disease. The American Journal of Pathology. 156: 489-99. PMID 10666378 DOI: 10.1016/S0002-9440(10)64753-0 |
0.318 |
|
| 2000 |
Mori C, Wisniewski K, Wisniewski T, Saido TC, Selkoe DJ, Lemere CA. Intraneuronal Aβ42 immunoreactivity is inversely correlated with Alzheimer's disease pathology in down syndrome brain: A temporal study Neurobiology of Aging. 21: 121. DOI: 10.1016/S0197-4580(00)82344-1 |
0.416 |
|
| 2000 |
Dowjat WK, Wisniewski T. Alzheimer's disease presenilin-1 regulates assembly of neurofilaments Neurobiology of Aging. 21: 110. DOI: 10.1016/S0197-4580(00)82293-9 |
0.379 |
|
| 1999 |
Aucouturier P, Kascsak RJ, Frangione B, Wisniewski T. Biochemical and conformational variability of human prion strains in sporadic Creutzfeldt-Jakob disease. Neuroscience Letters. 274: 33-6. PMID 10530513 DOI: 10.1016/S0304-3940(99)00659-X |
0.308 |
|
| 1999 |
Dowjat WK, Wisniewski T, Efthimiopoulos S, Wisniewski HM. Inhibition of neurite outgrowth by familial Alzheimer's disease-linked presenilin-1 mutations. Neuroscience Letters. 267: 141-4. PMID 10400232 DOI: 10.1016/S0304-3940(99)00351-1 |
0.364 |
|
| 1998 |
Pomara N, Shao B, Wisniewski T, Mehta PD. Decreases in plasma A beta 1-40 levels with aging in non-demented elderly with ApoE-epsilon 4 allele. Neurochemical Research. 23: 1563-6. PMID 9821162 DOI: 10.1023/A:1020936222286 |
0.338 |
|
| 1998 |
Wisniewski T, Aucouturier P, Soto C, Frangione B. The prionoses and other conformational disorders. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 5: 212-24. PMID 9818059 DOI: 10.3109/13506129809003848 |
0.464 |
|
| 1998 |
Wegiel J, Wisniewski HM, Kuchna I, Tarnawski M, Badmajew E, Popovitch E, Kulczycki J, Dowjat WK, Wisniewski T. Cell-type-specific enhancement of amyloid-beta deposition in a novel presenilin-1 mutation (P117L). Journal of Neuropathology and Experimental Neurology. 57: 831-8. PMID 9737546 DOI: 10.1097/00005072-199809000-00004 |
0.422 |
|
| 1998 |
Wisniewski T, Dowjat WK, Buxbaum JD, Khorkova O, Efthimiopoulos S, Kulczycki J, Lojkowska W, Wegiel J, Wisniewski HM, Frangione B. A novel Polish presenilin-1 mutation (P117L) is associated with familial Alzheimer's disease and leads to death as early as the age of 28 years. Neuroreport. 9: 217-21. PMID 9507958 DOI: 10.1097/00001756-199801260-00008 |
0.356 |
|
| 1997 |
Wisniewski T, Ghiso J, Frangione B. Biology of A beta amyloid in Alzheimer's disease. Neurobiology of Disease. 4: 313-28. PMID 9440120 DOI: 10.1006/Nbdi.1997.0147 |
0.387 |
|
| 1997 |
Permanne B, Perez C, Soto C, Frangione B, Wisniewski T. Detection of apolipoprotein E/dimeric soluble amyloid beta complexes in Alzheimer's disease brain supernatants. Biochemical and Biophysical Research Communications. 240: 715-20. PMID 9398632 DOI: 10.1006/Bbrc.1997.7727 |
0.458 |
|
| 1997 |
Wisniewski T, Dowjat WK, Permanne B, Palha J, Kumar A, Gallo G, Frangione B. Presenilin-1 is associated with Alzheimer's disease amyloid. The American Journal of Pathology. 151: 601-10. PMID 9250173 |
0.345 |
|
| 1997 |
Ghiso J, Calero M, Matsubara E, Governale S, Chuba J, Beavis R, Wisniewski T, Frangione B. Alzheimer's soluble amyloid beta is a normal component of human urine. Febs Letters. 408: 105-8. PMID 9180278 DOI: 10.1016/S0014-5793(97)00400-6 |
0.366 |
|
| 1996 |
Lemere CA, Blusztajn JK, Yamaguchi H, Wisniewski T, Saido TC, Selkoe DJ. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation. Neurobiology of Disease. 3: 16-32. PMID 9173910 DOI: 10.1006/Nbdi.1996.0003 |
0.35 |
|
| 1996 |
Lalowski M, Golabek A, Lemere CA, Selkoe DJ, Wisniewski HM, Beavis RC, Frangione B, Wisniewski T. The "nonamyloidogenic" p3 fragment (amyloid beta17-42) is a major constituent of Down's syndrome cerebellar preamyloid. The Journal of Biological Chemistry. 271: 33623-31. PMID 8969231 DOI: 10.1074/Jbc.271.52.33623 |
0.404 |
|
| 1996 |
Garzuly F, Vidal R, Wisniewski T, Brittig F, Budka H. Familial meningocerebrovascular amyloidosis, Hungarian type, with mutant transthyretin (TTR Asp18Gly) Neurology. 47: 1562-7. PMID 8960746 DOI: 10.1212/Wnl.47.6.1562 |
0.308 |
|
| 1996 |
Palha JA, Moreira P, Wisniewski T, Frangione B, Saraiva MJ. Transthyretin gene in Alzheimer's disease patients. Neuroscience Letters. 204: 212-4. PMID 8938268 DOI: 10.1016/0304-3940(96)12334-X |
0.444 |
|
| 1996 |
Frangione B, Castaño EM, Wisniewski T, Ghiso J, Prelli F, Vidal R. Apolipoprotein E and amyloidogenesis. Ciba Foundation Symposium. 199: 132-41; discussion 1. PMID 8915608 DOI: 10.1002/9780470514924.Ch9 |
0.366 |
|
| 1996 |
Wisniewski T, Frangione B. Molecular biology of brain aging and neurodegenerative disorders. Acta Neurobiologiae Experimentalis. 56: 267-79. PMID 8787186 |
0.307 |
|
| 1996 |
Soto C, Golabek A, Wisniewski T, Castaño EM. Alzheimer's beta-amyloid peptide is conformationally modified by apolipoprotein E in vitro. Neuroreport. 7: 721-5. PMID 8733730 DOI: 10.1097/00001756-199602290-00010 |
0.344 |
|
| 1996 |
Wisniewski T, Lalowski M, Baumann M, Rauvala H, Raulo E, Nolo R, Frangione B. HB-GAM is a cytokine present in Alzheimer's and Down's syndrome lesions. Neuroreport. 7: 667-71. PMID 8730853 DOI: 10.1097/00001756-199601310-00068 |
0.413 |
|
| 1996 |
Golabek AA, Soto C, Vogel T, Wisniewski T. The interaction between apolipoprotein E and Alzheimer's amyloid beta-peptide is dependent on beta-peptide conformation. The Journal of Biological Chemistry. 271: 10602-6. PMID 8631862 DOI: 10.1074/Jbc.271.18.10602 |
0.441 |
|
| 1996 |
Baumann MH, Wisniewski T, Levy E, Plant GT, Ghiso J. C-terminal fragments of alpha- and beta-tubulin form amyloid fibrils in vitro and associate with amyloid deposits of familial cerebral amyloid angiopathy, British type. Biochemical and Biophysical Research Communications. 219: 238-42. PMID 8619814 DOI: 10.1006/Bbrc.1996.0211 |
0.402 |
|
| 1996 |
Wisniewski T, Lalowski M, Bobik M, Russell M, Strosznajder J, Frangione B. Amyloid beta 1-42 deposits do not lead to Alzheimer's neuritic plaques in aged dogs. The Biochemical Journal. 313: 575-80. PMID 8573095 DOI: 10.1042/Bj3130575 |
0.359 |
|
| 1996 |
Golabek AA, Soto C, Wisniewski T. 700 Binding between apolipoprotein E and amyloid β is dependent on secondary structure Neurobiology of Aging. 17. DOI: 10.1016/S0197-4580(96)80702-0 |
0.306 |
|
| 1996 |
Boksay I, Tchernakov K, Myint Z, Reisberg B, Wisniewski T. 504 Medical conditions in Alzheimer's disease patients with 4/4 isotype of apolipoprotein E Neurobiology of Aging. 17. DOI: 10.1016/S0197-4580(96)80506-9 |
0.325 |
|
| 1995 |
Wisniewski T, Morelli L, Wegiel J, Levy E, Wisniewski HM, Frangione B. The influence of apolipoprotein E isotypes on Alzheimer's disease pathology in 40 cases of Down's syndrome. Annals of Neurology. 37: 136-8. PMID 7818249 DOI: 10.1002/Ana.410370128 |
0.345 |
|
| 1995 |
Ghiso J, Plant GT, Révész T, Wisniewski T, Frangione B. Familial cerebral amyloid angiopathy (British type) with nonneuritic amyloid plaque formation may be due to a novel amyloid protein. Journal of the Neurological Sciences. 129: 74-5. PMID 7751849 DOI: 10.1016/0022-510X(94)00274-R |
0.402 |
|
| 1995 |
Mangone CA, Castaño EM, Levy E, Abiusi G, Wisniewski T, Marques MR, Faccio E, Gorelick PB, Frangione B, Sica RE. Early onset Alzheimer's disease in a South American pedigree from Argentina. Acta Neurologica Scandinavica. 91: 6-13. PMID 7732777 DOI: 10.1111/J.1600-0404.1995.Tb05835.X |
0.381 |
|
| 1995 |
Wisniewski T, Lalowski M, Golabek A, Vogel T, Frangione B. Is Alzheimer's disease an apolipoprotein E amyloidosis? Lancet. 345: 956-8. PMID 7715296 DOI: 10.1016/S0140-6736(95)90701-7 |
0.411 |
|
| 1995 |
Wisniewski T, Frangione B. Amyloidosis in Alzheimer's disease. Lancet. 346: 441. PMID 7677907 DOI: 10.1016/S0140-6736(95)92812-X |
0.397 |
|
| 1995 |
Golabek A, Marques MA, Lalowski M, Wisniewski T. Amyloid beta binding proteins in vitro and in normal human cerebrospinal fluid. Neuroscience Letters. 191: 79-82. PMID 7659297 DOI: 10.1016/0304-3940(95)11565-7 |
0.448 |
|
| 1995 |
Wisniewski T, Golabek AA, Kida E, Wisniewski KE, Frangione B. Conformational mimicry in Alzheimer's disease. Role of apolipoproteins in amyloidogenesis. The American Journal of Pathology. 147: 238-44. PMID 7639323 |
0.328 |
|
| 1995 |
Castano EM, Prelli F, Wisniewski T, Golabek A, Kumar RA, Soto C, Frangione B. Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E. The Biochemical Journal. 306: 599-604. PMID 7534068 DOI: 10.1042/Bj3060599 |
0.436 |
|
| 1995 |
Wisniewski T, Palha JA, Ghiso J, Frangione B. S182 protein in Alzheimer's disease neuritic plaques. Lancet. 346: 1366. PMID 7475795 DOI: 10.1016/S0140-6736(95)92379-9 |
0.394 |
|
| 1994 |
Kida E, Golabek AA, Wisniewski T, Wisniewski KE. Regional differences in apolipoprotein E immunoreactivity in diffuse plaques in Alzheimer's disease brain. Neuroscience Letters. 167: 73-6. PMID 8177532 DOI: 10.1016/0304-3940(94)91030-8 |
0.384 |
|
| 1994 |
Wisniewski T, Lalowski M, Levy E, Marques MR, Frangione B. The amino acid sequence of neuritic plaque amyloid from a familial Alzheimer's disease patient. Annals of Neurology. 35: 245-6. PMID 8109908 DOI: 10.1002/Ana.410350223 |
0.372 |
|
| 1994 |
Sanan DA, Weisgraber KH, Russell SJ, Mahley RW, Huang D, Saunders A, Schmechel D, Wisniewski T, Frangione B, Roses AD. Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3. The Journal of Clinical Investigation. 94: 860-9. PMID 8040342 DOI: 10.1172/Jci117407 |
0.343 |
|
| 1994 |
Ghiso J, Wisniewski T, Frangione B. Unifying features of systemic and cerebral amyloidosis. Molecular Neurobiology. 8: 49-64. PMID 7916192 DOI: 10.1007/Bf02778007 |
0.431 |
|
| 1994 |
Wisniewski T, Ghiso J, Frangione B. Alzheimer's disease and soluble A beta. Neurobiology of Aging. 15: 143-52. PMID 7838284 DOI: 10.1016/0197-4580(94)90105-8 |
0.475 |
|
| 1994 |
Zlokovic BV, Martel CL, Mackic JB, Matsubara E, Wisniewski T, McComb JG, Frangione B, Ghiso J. Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer's amyloid beta. Biochemical and Biophysical Research Communications. 205: 1431-7. PMID 7802679 DOI: 10.1006/Bbrc.1994.2825 |
0.341 |
|
| 1994 |
Frangione B, Wisniewski T, Ghiso J. Chaperoning Alzheimer's amyloids. Neurobiology of Aging. 15: S97-9. PMID 7700474 DOI: 10.1016/0197-4580(94)90182-1 |
0.435 |
|
| 1993 |
Wisniewski T, Golabek A, Matsubara E, Ghiso J, Frangione B. Apolipoprotein E: binding to soluble Alzheimer's beta-amyloid. Biochemical and Biophysical Research Communications. 192: 359-65. PMID 8484748 DOI: 10.1006/Bbrc.1993.1423 |
0.385 |
|
| 1993 |
Ghiso J, Matsubara E, Koudinov A, Choi-Miura NH, Tomita M, Wisniewski T, Frangione B. The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex. The Biochemical Journal. 293: 27-30. PMID 8328966 DOI: 10.1042/Bj2930027 |
0.357 |
|
| 1993 |
Wisniewski T, Castano E, Ghiso J, Frangione B. Cerebrospinal fluid inhibits Alzheimer beta-amyloid fibril formation in vitro. Annals of Neurology. 34: 631-3. PMID 8215255 DOI: 10.1002/Ana.410340422 |
0.352 |
|
| 1993 |
Rodrigues MM, Rajagopalan S, Jones K, Nirankari V, Wisniewski T, Frangione B, Gorevic PD. Gelsolin immunoreactivity in corneal amyloid, wound healing, and macular and granular dystrophies. American Journal of Ophthalmology. 115: 644-52. PMID 7683843 DOI: 10.1016/S0002-9394(14)71464-3 |
0.355 |
|
| 1992 |
Wisniewski T, Frangione B. Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neuroscience Letters. 135: 235-8. PMID 1625800 DOI: 10.1016/0304-3940(92)90444-C |
0.372 |
|
| 1992 |
Wisniewski T, Frangione B. Molecular biology of Alzheimer's amyloid--Dutch variant. Molecular Neurobiology. 6: 75-86. PMID 1463589 DOI: 10.1007/Bf02935567 |
0.418 |
|
| 1992 |
Ghiso J, Wisniewski T, Vidal R, Rostagno A, Frangione B. Epitope map of two polyclonal antibodies that recognize amyloid lesions in patients with Alzheimer's disease. The Biochemical Journal. 282: 517-22. PMID 1372166 DOI: 10.1042/Bj2820517 |
0.383 |
|
| 1991 |
Castaño EM, Wisniewski T, Frangione B. Inherited amyloids of the nervous system. Current Opinion in Neurobiology. 1: 448-54. PMID 1821690 DOI: 10.1016/0959-4388(91)90068-I |
0.426 |
|
| 1991 |
Wisniewski T, Ghiso J, Frangione B. Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation. Biochemical and Biophysical Research Communications. 179: 1247-54. PMID 1681804 DOI: 10.1016/0006-291X(91)91706-I |
0.45 |
|
| 1991 |
Haltia M, Ghiso J, Wisniewski T, Kiuru S, Miller D, Frangione B. Gelsolin variant and beta-amyloid co-occur in a case of Alzheimer's with Lewy bodies. Neurobiology of Aging. 12: 313-6. PMID 1660109 DOI: 10.1016/0197-4580(91)90007-7 |
0.395 |
|
| Show low-probability matches. |